News
-
-
COMMUNIQUÉ DE PRESSE
Gemina Laboratories Sign First Strategic License Agreement
Gemina Laboratories Ltd. announces license agreement with global diagnostics company, validating its technology in the in vitro diagnostics market. CEO Brian Firth highlights cost-saving potential and future partnerships -
-
-
COMMUNIQUÉ DE PRESSE
Gemina Labs Strategic Update: Focusing on Respiratory Infections and Strategic Partnerships
Gemina Laboratories Ltd shares strategic update for 2024, focusing on revenue streams, partnerships, and new technologies for diagnostics. Company plans new protein production facility and market expansion -
-
-
COMMUNIQUÉ DE PRESSE
Gemina Announces Closing of $910,000 Convertible Note Financing
Gemina Laboratories Ltd. raises $910,000 through non-brokered private placement of unsecured convertible notes for general working capital and corporate purposes. Securities subject to holding period and outside Canada restrictions -
COMMUNIQUÉ DE PRESSE
Gemina Labs Ltd Appoints Stifel as Financial Advisor
-